BIOMEDIQ A/S
CVR 31176891 · Public limited company (A/S) · Active · High risk
BIOMEDIQ A/S is a Public limited company (A/S), founded on , based in København K. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 4.5% over the next 12 months, which is 3.2 times the average for Danish companies. 18 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -979k and a net result of DKK -977k. CEO: Mads Nielsen.
Bankruptcy risk for BIOMEDIQ A/S
4.5%
probability of bankruptcy within 12 months
High risk
3.2 × the average (1.41%) · higher risk than 91% of active Danish companies
Lowest riskHighest risk
Increases the risk
Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Reduces the risk
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Company typeA/S · bankruptcy rate 4.4%0.50×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 31176891
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (18 years)
- Address
- Danneskiold-Samsøes Allé 41, st.
1434 København K - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 400k
- Employees
- 5 (2018)
- Auditor
- DANSK REVISION SØBORG, STATSAUTORISERET REVISIONSAKTIESELSKAB
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 18 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -315.5% |
| Current ratio | 24% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 6 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 90 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -305k | DKK -75k |
| Net profit | DKK -977k | DKK -57k |
| Equity | DKK -979k | DKK -2,399 |
| Total assets | DKK 310k | DKK 40k |
| Cash | DKK 245k | – |
| Short-term debt | DKK 1.3m | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · DANSK REVISION SØBORG, STATSAUTORISERET REVISIONSAKTIESELSKAB.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 153 | ||
| 1 Jan 2024 – 31 Dec 2024 | 177 | ||
| 1 Jan 2023 – 31 Dec 2023 | 169 | ||
| 1 Jan 2022 – 31 Dec 2022 | 162 | ||
| 1 Jan 2021 – 31 Dec 2021 | 151 | ||
| 1 Jan 2020 – 31 Dec 2020 | 182 | ||
| 1 Jan 2019 – 31 Dec 2019 | 237 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 172 | ||
| 1 Jan 2017 – 31 Dec 2017 | 169 | ||
| 1 Jan 2016 – 31 Dec 2016 | 153 | ||
| 1 Jan 2015 – 31 Dec 2015 | 169 | ||
| 1 Jan 2014 – 31 Dec 2014 | 146 | ||
| 1 Jan 2013 – 31 Dec 2013 | 153 | ||
| 1 Jan 2012 – 31 Dec 2012 | 155 | ||
| 1 Jan 2011 – 31 Dec 2011 | 150 | ||
| 1 Jan 2010 – 31 Dec 2010 | 160 | ||
| 1 Jan 2009 – 31 Dec 2009 | 153 | ||
| 1 Jan 2008 – 31 Dec 2008 | 165 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mads Nielsen | Current | |
| CEO | Claus Henrik Christiansen | ||
| CEO | Thomas Nielsen | ||
| CEO | Søren Hyllekvist | ||
| Board | Martin Lillholm | Current | |
| Board | Mads Nielsen | Current | |
| Board | Pieter Kroese | Current | |
| Board | Claus Henrik Christiansen | ||
| Board | Thomas Nielsen | ||
| Board | Morten Asser Karsdal | ||
| Board | Aaron Christopher Timm | ||
| Board | Ralph J. Reyes | ||
| Board | Erik Bjørnager Dam | ||
| Board | Claus Henrik Christiansen | ||
| Board | Thomas Nielsen | ||
| Owner (100%) | Screenpoint Medical B.V | Current | |
| Owner (33%) | Stayrelevant-it ApS | ||
| Owner (20%) | EBD EDB ApS | ||
| Owner (20%) | MØLLEHOLM ApS | ||
| Owner (20%) | DEN DANSKE FORSKNINGSFOND | ||
| Owner (50%) | Mads Nielsen Holding ApS | ||
| Owner (50%) | Mads Nielsen Holding 1 ApS | ||
| Auditor | Brink Larse /Athos, Statsautoriseret Revisionsvirksomhed I/S | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | REVISOR HANS BEIER ApS | ||
| Auditor | BRØNSHØJ REVISION ApS GODKENDTE REVISORER | ||
| Auditor | CARSTEN C. HOFF REGNSKAB ApS | ||
| Auditor | AIDER Godkendt Revisionsaktieselskab | ||
| Auditor | DANSK REVISION SØBORG, STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Founder | NORDIC BIOSCIENCE A/S | Current |
The CEOs' other companies
Mads Nielsen – 10 other companies, of which 1 bankrupt
- GENERIC VISION ApS Bankrupt 5 Aug 2002
- Aiomic ApS Active
- Cerebriu A/S Active
- GENERIC VISION HOLDING ApS Compulsorily dissolved
- Mads Nielsen Holding 1 ApS Active
- Mads Nielsen Holding ApS Fusioneret
- Prenaital ApS Active
- SONAI Medical Holding ApS Active
- Stayrelevant-it ApS Active
- Tanja Danner Holding ApS Active
Claus Henrik Christiansen – 44 other companies, of which 2 bankrupt
- DDD-DIAGNOSTIC A/S Bankrupt 13 Jun 2023
- MEJER & MUNKSGAARD A/S Bankrupt 20 Nov 2000
- 3D HOLDING A/S Opløst
- ARKA HOLDING ApS Opløst
- C.C. CONSULTING A/S Opløst
- C4PAIN ApS Active
- CACLAURIIS ApS Opløst
- CC & D ApS Opløst
- CCBR GROUP A/S Opløst
- CKL ApS Opløst
- CON-2009 HOLDING A/S Opløst
- Center for Clinical and Basic Research A/S Active
- GFKJUS 597 ApS Opløst
- HC NORDIC ApS Compulsorily dissolved
- IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S Opløst
- INVESTERINGSSELSKABET AF 20.12.1995. HERLEV ApS Opløst
- NBCD A/S Active
- NORDIC BIOSCIENCE A/S Active
- NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S Fusioneret
- NORDIC BIOSCIENCE CLINICAL STUDIES A/S Opløst
- NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S Opløst
- NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S Fusioneret
- NORDIC BIOSCIENCE HOLDING A/S Active
- NORDIC BIOSCIENCE LABORATORY A/S Opløst
- OSTEOMETER A/S Fusioneret
- OSTEOMETER MEDITECH A/S Opløst
- OSTEOPRESS ApS Opløst
- Oregano ApS Active
- PRICE INVENA ApS Active
- PRIDE PROTEOMICS A/S Fusioneret
Thomas Nielsen – 30 other companies
- Alma Madmarked A/S Active
- ApS DANCO INVESTMENTS Fusioneret
- CCBR GROUP A/S Opløst
- Center for Clinical and Basic Research A/S Active
- DDF PROPERTIES ApS Opløst
- DESCOM A/S Active
- E-EJENDOMME ApS Compulsorily dissolved
- IMPACT IT ApS Opløst
- ITERIUM ApS Fusioneret
- Lund Clifford Holding ApS Active
- Miramare ApS Active
- NBCD A/S Active
- NER ApS Compulsorily dissolved
- NORDIC BIOSCIENCE A/S Active
- NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S Fusioneret
- NORDIC BIOSCIENCE CLINICAL STUDIES A/S Opløst
- NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S Opløst
- NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S Fusioneret
- NORDIC BIOSCIENCE LABORATORY A/S Opløst
- Nordic Clays ApS Active
- Nordic Life Science Consulting ApS Active
- Oregano ApS Active
- PE-INVEST ApS Compulsorily dissolved
- RHEOSCIENCE ApS Opløst
- RISMA SYSTEMS A/S Active
- Romarine ApS Active
- Sanos A/S Active
- Sanos Holding A/S Active
- Sunshine Enterprise Holding A/S Active
- Symic OA ApS Active
Søren Hyllekvist – 5 other companies
- Center for Clinical and Basic Research A/S Active
- KOMPLEMENTARSELSKABET SHL ApS Active
- NORDIC BIOSCIENCE LABORATORY A/S Opløst
- SHL Partner ApS Active
- Sunshine Enterprise Holding A/S Active
Address history (5 moves)
| Danneskiold-Samsøes Allé 41, st., 1434 København K | |
| c/o Mads Nielsen, Strandlinien 59, 2791 Dragør | |
| Fruebjergvej 3, 2100 København Ø | |
| Glerupvej 2, 2610 Rødovre | |
| Ballerup Byvej 222, 2750 Ballerup | |
| Herlev Hovedgade 207, 2730 Herlev |
Former names
| BIOMEDIQ A/S | – now |
| SYNARC IMAGING TECHNOLOGY A/S | – |
| NORDIC BIOSCIENCE IMAGING A/S | – |
Employees per year
Other companies at the same address
- Africa Reframed IVS Bankrupt
- Booost Digital ApS Bankrupt
- Copenhagen hubs IVS Bankrupt
- Inflightment ApS Bankrupt
- ONEONETEN IVS Bankrupt
- SNAPLYTICS IVS Bankrupt
- Simpelhed ApS Bankrupt
- Simpelt Byggeri ApS Bankrupt
- Sprinthero ApS Bankrupt
- TRADETRACKER DENMARK ApS Bankrupt
- Thomas Damgård Holding IVS Bankrupt
- WOOMIO ApS Bankrupt
- reWear it ApS Bankrupt
- 3DBYGGERI DANMARK ApS Active
- ATECH HEALTH ApS Active
- ATECH HEALTH HOLDING ApS Active
- Adent ApS Active
- Aimo ApS Opløst
- BarMachina ApS Opløst
- BeScord Aps Opløst
- Briota ApS Active
- CONTINGENT VENTURES ApS Fusioneret
- Celsius Health ApS Active
- Cerebriu A/S Active
- Companyshop ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about BIOMEDIQ A/S
Has BIOMEDIQ A/S gone bankrupt?
No, BIOMEDIQ A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BIOMEDIQ A/S?
Our model estimates a bankruptcy risk of 4.5% over the next 12 months (high risk), which is 3.2 times the average for Danish companies.
Who is the CEO of BIOMEDIQ A/S?
Mads Nielsen is the CEO of BIOMEDIQ A/S.
Who is the auditor of BIOMEDIQ A/S?
BIOMEDIQ A/S most recently used DANSK REVISION SØBORG, STATSAUTORISERET REVISIONSAKTIESELSKAB.
When was BIOMEDIQ A/S founded?
BIOMEDIQ A/S was founded on 1 January 2008.
What is the equity of BIOMEDIQ A/S?
Equity was DKK -979k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.